Worth reading
51Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.This transaction
Acquisition of shares in 株式会社マリン・プロフーズ (making the company a subsidiary)CounterpartyInvestment Business Limited Partnership “DPIP Corporate Support No. 1”
Disclosing companyPharma Foods International Co.,Ltd.
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
Execution Date / Effective Date30 October 2026 (completed)
Target company
Planning, development and sale of agricultural, livestock and marine products and processed soybean products
Location Chiyoda-ku, TokyoShare capital ¥100 millionDate of incorporation 11 November 2021
Impact on Business Performance
Currently under review
Procedures and assumptions
Management structure after acquisitionThe representative of the target company is stated as Representative Director and President Kishi Takashi (岸 孝史), but the post-acquisition management structure is not disclosed
| Item | Details |
|---|---|
| Transaction name | Acquisition of shares in 株式会社マリン・プロフーズ (making the company a subsidiary) |
| Counterparty name | Investment Business Limited Partnership “DPIP Corporate Support No. 1” |
| Name of the Subject Company | 株式会社マリン・プロフーズ |
| Business Description of the Subject Company | Planning, development and sale of agricultural, livestock and marine products and processed soybean products |
| Location of the Subject Company | Chiyoda-ku, Tokyo |
| Capital Stock of the Subject Company | ¥100 million |
| Date of Establishment of the Subject Company | 11 November 2021 |
| Number of shares acquired | All shares (number of shares not disclosed) |
| Voting rights ownership percentage | After 100% (acquisition of all shares) (before not disclosed) |
| Impact on Business Performance | Currently under review |
| Execution Date / Effective Date | 30 October 2026 (completed) |
| Management structure after acquisition | The representative of the target company is stated as Representative Director and President Kishi Takashi (岸 孝史), but the post-acquisition management structure is not disclosed |
Items this document does not state (20)
Net Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Date of board resolutionContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to Execution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The reason for the transaction is not stated.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.